Skip to main content
Figure 3 | BMC Neurology

Figure 3

From: Mechanosensitivity during lower extremity neurodynamic testing is diminished in individuals with Type 2 Diabetes Mellitus and peripheral neuropathy: a cross sectional study

Figure 3

Reported symptom locations during SLR neurodynamic testing. Body chart representations are presented for frequencies of symptom location reported during SLR testing. A, B, C represents PF/SLR at the START, onset of symptoms (P1) and the maximally tolerated position (P2), respectively. D, E, F represents DF/SLR at the START, onset of symptoms (P1) and the maximally tolerated position (P2), respectively. Frequencies are reported in 10% intervals from a white color of 0% frequency to 90-100% as dark red (see key in center of figure). There were >15% bilateral symptoms in the feet at the START position for both PF/SLR and DF/SLR. There were more frequent right posterior leg symptoms in the DF/SLR test when compared to the PF/SLR at P2.

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us